Patients with ITP commonly display a disrupted Th1/Th2 cellular equilibrium, heightened Th17 cell populations, increased IL‐17 secretion, as well as decreased numbers and defective regulatory function of Tregs, collectively leading to compromised immunological tolerance. This evidence concerns the gene IL17A and autoimmune thrombocytopenic purpura.